Page 152 - EJMO-9-3

Eurasian Journal of
Medicine and Oncology CRCI factors in breast cancer

independent determinants of cognitive function in breast 2021071609). Written informed consent for participation
cancer patients undergoing chemotherapy. Furthermore, in the study was obtained from all participants before their
depression was found to mediate the relationship between involvement.
social support and cognitive function. Consequently,
the cognitive dysfunction observed in breast cancer Consent for publication
patients post-chemotherapy is influenced by a multitude Written consent from the patient to report individual data
of factors. This necessitates heightened awareness among for publication was obtained.
healthcare professionals, the development of scientifically
grounded intervention strategies, the enhancement of Availability of data
social support, and efforts to aid patients in improving Data are available from the corresponding author on
their cognitive function. This study proposes that cancer- reasonable request.
related cognitive dysfunction can be ameliorated through
the implementation of cognitive-enhancing strategies References
in clinical practice. This includes instructing patients in 1. WHO. Latest Global Cancer Data: Cancer Burden Rises to 19.3
these strategies, advising them to engage in cognitively Million New Cases and 10.0 Million Cancer Deaths in 2022
demanding tasks during periods of optimal cognitive Questions and Answers (Q and A). Switzerland: WHO; 2024.
functioning, and administering cognitive behavioral
interventions when deemed necessary. However, we did 2. Yang S, Zheng L, Sun Y, Li Z. Effect of network-based
not investigate the relationship between biochemical positive psychological nursing model combined with
elemene injection on negative emotions, immune function
parameters and cognitive functioning. Further in-depth and quality of life in lung cancer patients undergoing
observation and analysis in the follow-up study are chemotherapy in the era of big data. Front Public Health.
warranted. 2022;10:897535.

Acknowledgments doi: 10.3389/fpubh.2022.897535
None. 3. Országhová Z, Mego M, Chovanec M. Long-term
cognitive dysfunction in cancer survivors. Front Mol Biosci.
Funding 2021;8:770413.
doi: 10.3389/fmolb.2021.770413
This research was funded by the Beijing Sisco Clinical
Oncology Research Fund (grant number Y-L2020-0013), 4. Lange M, Joly F, Vardy J, et al. Cancer-related cognitive
the Shaanxi Clinical Medical Research Center for Breast impairment: An update on state of the art, detection, and
Diseases (grant number 2024SF-LCZX-08), the Natural management strategies in cancer survivors. Ann Oncol.
Science Basic Research Program of Shaanxi Province (grant 2019;30(12):1925-1940.
number 2023-JC-YB-345), Shaanxi Provincial People’s doi: 10.1093/annonc/mdz410
Hospital Elite Talent Project (grant number 2022-JY46), 5. American Cancer Society. Chemo Brain[EB/OL]; 2023.
and the Shaanxi Provincial People’s Hospital incubation Available from: https://www.cancer.org/treatment/
fund project (grant number 2022YJY-57). treatments-and-side-effects/physical-side-effects/changes-
in-mood-or-thinking/chemo-brain.html [Last accessed on
Conflict of interest 2025 May 29].
The authors declare no conflicts of interest. 6. And Alternative Medicine EC. Changes and influencing
factors of cognitive impairment in patients with breast cancer.
Author contributions Evid Based Complement Alternat Med. 2023;2023:9872082.
Conceptualization: Ying Zhang, Liping Yang doi: 10.1155/2023/9872082
Data curation: Ying Zhang, Nan Jiang 7. Tyagi K, Masoom M, Majid H, et al. Role of cytokines in
Formal analysis: Ying Zhang, Yunmiao Ma chemotherapy-related cognitive impairment of breast cancer
Methodology: Bo Tian, Kenian Pan, Jianhui Li patients: A systematic review. Curr Rev Clin Exp Pharmacol.
Writing – original draft: Shuhan Wu 2023;18(2):110-119.
Writing – review & editing: Shuyang Chang, Xulong Zhu doi: 10.2174/2772432817666220304212456
Ethics approval and consent to participate 8. Rodríguez Martín B, Fernández Rodríguez EJ, Rihuete
Galve MI, Cruz Hernández JJ. Study of chemotherapy-
This work received ethical approval from the Shaanxi induced cognitive impairment in women with breast cancer.
Provincial People’s Hospital Ethics Board (Project number: Int J Environ Res Public Health. 2020;17(23):8896.

Volume 9 Issue 3 (2025) 144 doi: 10.36922/EJMO025130073